Cite
HARVARD Citation
Dummer, R. et al. (2020). Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study. British journal of dermatology. pp. 1369-1378. [Online].